Cerebrospinal fluid levels of α-secretase-cleaved soluble amyloid precursor protein mirror cognition in a Swedish family with Alzheimer disease and a gene mutation

Archives of Neurology

Volumn 54, Issue 5, 1997, Pages 641-644

  Almkvist, Ove ^a   Basun, Hans ^a   Wagner, Steven L ^b   Rowe, Blake A ^b   Wahlund, Lars Olof ^a   Lannfelt, Lars ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^b MERCK RESEARCH LABORATORIES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA SECRETASE; AMYLOID BETA PROTEIN; AMYLOID PRECURSOR PROTEIN; BIOLOGICAL MARKER; ENZYME; UNCLASSIFIED DRUG;

ADULT; ALZHEIMER DISEASE; ARTICLE; CEREBROSPINAL FLUID LEVEL; CLINICAL ARTICLE; COGNITION; FEMALE; GENE MUTATION; HUMAN; MALE; PRIORITY JOURNAL; PROTEIN DEGRADATION; SWEDEN;

EID: 0030974261     PISSN: 00039942     EISSN: None     Source Type: Journal    
DOI: 10.1001/archneur.1997.00550170111022     Document Type: Article

References (20)

1. Lannfelt L, Basun B, Wahlund L-O, Rowe BA, Wagner S. Decreased cerebrospinal fluid α-secretase cleaved amyloid precursor protein as a diagnostic marker for Alzheimer's disease. Nat Med. 1995;1:829-832.
2. Lannfelt L, Basun H, Vigo-Pelfrey G, et al. Amyloid β-peptide in cerebrospinal fluid in individuals with the Swedish Alzheimer amyloid precursor protein mutation. Neurosci Lett. 1995;199:203-206.
3. Mullan M, Crawford F, Axelman K, et al. A pathogenic mutation for probable Alzheimer's disease in the APR gene at the N-terminus of β-amyloid, Nat Genet. 1992;1:345-347.
4. Axelman K, Basun H, Winblad B, Lannfelt L. A large Swedish family with Alzheimer's disease with a codon 670/671 amyloid precursor protein mutation: a clinical and genealogical investigation. Arch Neurol. 1994;51:1193-1197.
5. Haass C, Selkoe DJ. Cellular processing of β-amyloid precursor protein and the genesis of amyloid β-peptide. Cell. 1993;75:1039-1042.
6. Folstein MF, Folstein SE, McHugh PR. 'Mini-Mental State': a practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res. 1975;12:189-198.
7. Van Nostrand WL, Wagner SL, Shankle WR, et al. Decreased levels of soluble amyloid β-protein precursor in cerebrospinal fluid of live Alzheimer disease patients. Proc Natl Acad Sci USA. 1992;89:2551-2555.
8. Farlow M, Ghetti B, Benson MD, Farrow JS, Van Nostrand WE, Wagner SL. Low cerebrospinal-fluid concentrations of soluble amyloid β-protein precursor in hereditary Alzheimer's disease. Lancet. 1992;340:453-454.
9. Wagner SL, Peskind ER, Nochlin D, et al. Decreased levels of soluble amyloid β-protein precursor are associated with Alzheimer's disease in concordant and discordant monozygous twin pairs. Ann Neurol. 1994;36:215-220.
10. van Gool WA, Kuiper MA, Walstra GJM, Wolters EC, Bolhuis PA. Concentrations of amyloid β protein in cerebrospinal fluid of patients with Alzheimer's disease. Ann Neurol. 1995;37:277-279.
11. Nitsch RM, Rebeck GW, Deng M, et al. Cerebrospinal fluid levels of amyloid β-protein in Alzheimer's disease: inverse correlation with severity of dementia and effect of apolipoprotein E genotype. Ann Neurol. 1995;37:512-518.
12. 42 in the cerebrospinal fluid of patients with Alzheimer's disease. Ann Neurol. 1995;38:643-648.
13. Lannfelt L, Bogdanovic N, Appelgren H, et al. Amyloid precursor protein mutation causes Alzheimer's disease in a Swedish family. Neurosci Lett. 1994;168:254-256.
14. McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ARDRA work group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology. 1984;34:939-944.
15. Almkvist O, Basun H, Wahlund LO, Lannfelt L. Cognitive functions of family members with and without the APP670/671 mutation. In: Iqbal K, Mortimer JA, Winblad B, Wisniewski HM, eds. Research Advances in Alzneimer's Disease and Related Disorders. New York, NY: John Wiley & Sons Inc; 1995:251-259.
16. Almkvist O. Neuropsychological features of early Alzheimer's disease: preclinical and clinical stages. Acta Neurol Scand Suppl. 1996;165:63-71.
17. Wechsler D. Wechsler Adult Intelligence Scale-Revised: Manual. New York, NY: Psychological Corp; 1981.
18. Prior R, Mönning U, Schreiter-Gasser U, et al. Quantitative changes in the amyloid αA4 precursor protein in Alzheimer cerebrospinal fluid. Neurosci Lett. 1991;124:69-73.
19. Nakamura T, Shoij M, Harigaya Y, et al. Amyloid β protein levels in cerebrospinal fluid are elevated in early-onset Alzheimer's disease. Ann Neurol. 1994;36:903-911.
20. Wagner SL. Biological functions of the amyloid β-protein precursor. In: Goate A, Ashall F, eds. Pathobiology of Alzheimer's Disease. Orlando, Fla: Academic Press Inc; 1995:167-182.